Home › Obesity › Louisiana › Metairie
Obesity clinical trials in Metairie, LA
5 studies for Obesity are looking for participants at sites in and around Metairie (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- Clinical Trials Management, LLC d/b/a Flourish Research, Metairie
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Metairie
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- Northshore Heart and Vascular LLC, Mandeville · 26 mi away
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
- Nola Care Clinical Research Center, Metairie
Collaborative Multi-level Obesity Intervention Engaging Communities Trial
Recruiting
- InclusivCare - Kenner Clinic, Kenner · 5 mi away
- InclusivCare - Avondale Clinic, Avondale · 6 mi away
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX43 studies
- Chicago, IL41 studies
- New York City, NY40 studies
- San Antonio, TX40 studies
- Washington, DC33 studies
- Orlando, FL32 studies
- Dallas, TX30 studies
- Boston, MA28 studies
- Miami, FL27 studies
- Las Vegas, NV27 studies
- Baltimore, MD26 studies
- Jacksonville, FL25 studies
Other studies in Metairie
- Prostate Cancer12 studies
- Ulcerative Colitis8 studies
- Bladder Cancer6 studies
- Type 2 Diabetes5 studies
- Crohn's Disease5 studies
- Steatotic Liver Disease4 studies
- Metastatic Cancer4 studies
- Cardiovascular Disease4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Neuroendocrine Tumors3 studies
- Urothelial (Transitional Cell) Carcinoma3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.